a public good project by the
Synthesis
Company
of California

© 2026

Najam Gohar | doi.page

0 works0 citations0 h-index

Najam Gohar

Lahore General Hospital(PK)University of Pittsburgh Medical Center(US)Post Graduate Medical Institute(PK)Jersey Shore University Medical Center(US)The University of Texas Medical Branch at Galveston(US)

Publications by Year

Research Areas

Pulmonary Hypertension Research and Treatments, Heart Failure Treatment and Management, Cancer Risks and Factors, Chronic Disease Management Strategies, Alzheimer's disease research and treatments

Most-Cited Works

→ Temporal and demographic disparities in mortality trends for heart failure and COPD-associated heart failure in U.S. Adults: A 1999–2020 analysis of CDC WONDER data(2025)4 cited
→ Efficacy and Safety of 10‐Day Versus 14‐Day Bismuth‐Containing Quadruple Therapy for Helicobacter pylori Eradication: A Systematic Review and Meta‐Analysis(2025)3 cited
→ Comparative diagnostic accuracy of artificial intelligence-derived risk stratification versus conventional risk stratification methods in pulmonary hypertension patients: a systematic review and meta-analysis(2025)1 cited
→ SUN-036 Trends and Disparities in Neurological Complications Associated Mortality Among Individuals with Type 2 Diabetes Mellitus in The United States from 1999 to 2020: A CDC Wonder Analysis.(2025)1 cited
→ Impact of P2Y₁₂ Inhibitor Pretreatment on Clinical Outcomes in ST‐Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention: A Retrospective Cohort Study(2025)1 cited

→ Mortality trends in metabolic syndrome and colorectal, endometrial, and breast cancers in the US (1999–2020).(2025)

→ Trends and disparities in amyloidosis and cardiovascular disease mortality: a population-based retrospective study in the United States (1999–2020)(2026)

→ Gender, place of death, and racial disparities in the reporting odds ratio of cardiovascular disease burden in leukemia across age groups (15–85) in the U.S.: A CDC WONDER disproportionality analysis.(2025)

→ Extended Dual Versus Single Anti‐Platelet Therapy Following Percutaneous Coronary Intervention: A Bayesian Meta‐Analysis and Regression on All‐Cause Mortality(2025)

→ Impact of Peri‐Procedural Red Blood Cell Transfusion on Clinical Outcomes in Transcatheter Aortic Valve Replacement: A Propensity‐Matched Cohort Study(2026)